Form 4: HealthStream Director Deborah Taylor Tate Boosts Stake Through RSU Vesting

HealthStream Inc. Director Deborah Taylor Tate acquired 2,132 shares of common stock through the vesting of restricted share units, increasing her direct beneficial ownership to 24,707 shares.

Summary

• Deborah Taylor Tate, a Director at HealthStream Inc. (HSTM), acquired 2,132 shares of common stock on June 9, 2025.
• The acquisition was a result of the vesting of restricted share units (RSUs), with an acquisition price of $0 per share.
• Following this transaction, Ms. Tate's direct beneficial ownership of HealthStream common stock increased to 24,707 shares.
• The shares acquired include 1,126 shares from RSUs subject to a three-year vesting schedule that began on June 6, 2024, vesting annually in three equal installments.
• Additionally, 1,006 shares were acquired from RSUs subject to a separate three-year vesting schedule that began on May 30, 2025, also vesting annually in three equal installments.
• After the reported transactions, Ms. Tate still holds 1,126 restricted share units from the first grant and 2,012 restricted share units from the second grant, which are yet to vest.

Sentiment

Score: 7

Explanation: The transaction is a routine vesting of restricted share units, which increases the director's direct ownership and aligns her interests with shareholders, generally viewed as a positive or neutral event.

Positives

• The acquisition of shares through RSU vesting increases the director's direct ownership in the company, further aligning her interests with those of shareholders.
• The transaction is a routine part of executive compensation, indicating stability in the company's compensation practices.

Future Outlook

The document indicates future vesting installments for the remaining restricted share units held by Deborah Taylor Tate, contingent upon her continued service.

Industry Context

This Form 4 filing details a routine insider transaction related to equity compensation. It is common practice for directors and executives in publicly traded companies across various industries to receive restricted stock units as part of their compensation packages, which vest over time to align their long-term interests with company performance.

Stakeholder Impact

• Shareholders: Increased alignment of director's interests with shareholders due to higher direct ownership, potentially fostering confidence in management's commitment.

Next Steps

• Future annual vesting installments for the remaining 1,126 restricted share units (from the June 6, 2024 grant).
• Future annual vesting installments for the remaining 2,012 restricted share units (from the May 30, 2025 grant).

Key Dates

Recommendation

Keywords

HealthStream, HSTM, SEC Form 4, Insider Transaction, Restricted Share Units, RSU Vesting, Director Stock Ownership, Corporate Governance, Equity Compensation